InsiderTrades.com logo

ESPR Insider Trading

Insider Ownership Percentage: 1.70%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $59,811.61

Esperion Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Esperion Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Esperion Therapeutics Share Price & Price History

Current Price: $3.79
Price Change: ▲ Price Increase of +0.01 (0.26%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for ESPR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Esperion Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/17/2025Benjamin HalladayCFOSell7,046$2.81$19,799.26474,862View SEC Filing Icon  
9/17/2025Benjamin LookerGeneral CounselSell6,267$2.80$17,547.60393,670View SEC Filing Icon  
7/17/2025Benjamin HalladayCFOSell11$1.11$12.21474,462View SEC Filing Icon  
7/17/2025Benjamin LookerGeneral CounselSell1,304$1.13$1,473.52399,937View SEC Filing Icon  
6/17/2025Benjamin HalladayCFOSell7,229$1.15$8,313.35474,473View SEC Filing Icon  
6/17/2025Benjamin LookerGeneral CounselSell6,422$1.15$7,385.30401,241View SEC Filing Icon  
4/17/2025Benjamin HalladayCFOSell8$0.96$7.68481,702View SEC Filing Icon  
3/18/2025Benjamin HalladayCFOSell3,535$1.48$5,231.80481,710View SEC Filing Icon  
2/19/2025Benjamin HalladayCFOSell11$1.86$20.46240,671View SEC Filing Icon  
1/17/2025Benjamin HalladayCFOSell9$2.27$20.43240,682View SEC Filing Icon  
10/17/2024Eric WarrenInsiderSell107$2.12$226.84162,552View SEC Filing Icon  
7/17/2024Eric WarrenInsiderSell108$2.59$279.72165,478View SEC Filing Icon  
9/20/2023Eric WarrenInsiderSell742$1.25$927.5068,318View SEC Filing Icon  
8/18/2023Eric WarrenInsiderSell243$1.41$342.6369,060View SEC Filing Icon  
7/19/2023Eric WarrenInsiderSell106$1.58$167.4869,303View SEC Filing Icon  
6/21/2023Eric WarrenInsiderSell603$1.48$892.4469,409View SEC Filing Icon  
5/17/2023Eric WarrenInsiderSell219$1.62$354.7870,012View SEC Filing Icon  
5/10/2023J Martin CarrollDirectorBuy8,409$1.49$12,529.4113,409View SEC Filing Icon  
5/9/2023Sheldon L KoenigCEOBuy20,000$1.26$25,200.00312,816View SEC Filing Icon  
4/19/2023Benjamin LookerGeneral CounselSell1,290$1.27$1,638.3083,663View SEC Filing Icon  
4/19/2023Eric WarrenInsiderSell115$1.28$147.2070,231View SEC Filing Icon  
3/17/2023Joanne M FoodyInsiderSell3,808$1.78$6,778.24128,002View SEC Filing Icon  
3/17/2023Sheldon L KoenigCEOSell6,999$1.78$12,458.22292,816View SEC Filing Icon  
3/7/2023Eric WarrenInsiderSell5,090$5.05$25,704.5048,572View SEC Filing Icon  
3/7/2023Sheldon L KoenigCEOSell5,441$5.06$27,531.46194,815View SEC Filing Icon  
1/18/2023Benjamin LookerGeneral CounselSell6,347$7.00$44,429.0064,453View SEC Filing Icon  
1/18/2023Joanne M FoodyInsiderSell1,191$6.99$8,325.09106,944View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Esperion Therapeutics (NASDAQ:ESPR)

47.39% of Esperion Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ESPR by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Esperion Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/21/2025CIBC Bancorp USA Inc.21,286$56K0.0%N/A0.009%Search for SEC Filing on Google Icon
11/19/2025Caitong International Asset Management Co. Ltd31,252$83K0.1%+40,487.0%0.013%Search for SEC Filing on Google Icon
11/17/2025Eaton Financial Holdings Company LLC42,595$0.11M0.0%N/A0.018%Search for SEC Filing on Google Icon
11/17/2025Woodline Partners LP382,087$1.01M0.0%-74.6%0.160%Search for SEC Filing on Google Icon
11/17/2025Two Seas Capital LP9,749,724$25.84M0.4%-2.1%4.078%Search for SEC Filing on Google Icon
11/17/2025Voleon Capital Management LP207,880$0.55M0.0%N/A0.087%Search for SEC Filing on Google Icon
11/17/2025Wasatch Advisors LP7,061,857$18.71M0.1%-31.7%2.954%Search for SEC Filing on Google Icon
11/17/2025Prelude Capital Management LLC65,327$0.17M0.0%-75.4%0.027%Search for SEC Filing on Google Icon
11/17/2025Mariner LLC302,514$0.80M0.0%N/A0.127%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC974,856$2.58M0.0%+115.4%0.408%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.93,773$0.25M0.0%-12.8%0.039%Search for SEC Filing on Google Icon
11/17/2025Brevan Howard Capital Management LP263,276$0.70M0.0%+234.5%0.110%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE304,572$0.81M0.0%-63.6%0.127%Search for SEC Filing on Google Icon
11/17/2025Alliancebernstein L.P.211,760$0.56M0.0%-24.3%0.089%Search for SEC Filing on Google Icon
11/14/2025Raymond James Financial Inc.60,093$0.16M0.0%+46.4%0.025%Search for SEC Filing on Google Icon
11/14/2025Equitable Holdings Inc.23,400$62K0.0%N/A0.010%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP2,238,618$5.93M0.0%+22.5%0.936%Search for SEC Filing on Google Icon
11/14/2025Squarepoint Ops LLC296,811$0.79M0.0%+38.4%0.124%Search for SEC Filing on Google Icon
11/14/2025Integral Health Asset Management LLC1,500,000$3.98M0.3%N/A0.627%Search for SEC Filing on Google Icon
11/14/2025Arrowpoint Investment Partners Singapore Pte. Ltd.40,487$0.11M0.1%N/A0.017%Search for SEC Filing on Google Icon
11/13/2025Marshall Wace LLP2,521,439$6.68M0.0%-52.5%1.055%Search for SEC Filing on Google Icon
11/13/2025Tocqueville Asset Management L.P.91,000$0.24M0.0%+43.3%0.038%Search for SEC Filing on Google Icon
11/13/2025Sei Investments Co.77,751$0.21M0.0%N/A0.033%Search for SEC Filing on Google Icon
11/13/2025BOKF NA24,023$64K0.0%+101.8%0.010%Search for SEC Filing on Google Icon
11/13/2025UBS Group AG1,246,310$3.30M0.0%-18.9%0.521%Search for SEC Filing on Google Icon
11/13/2025BNP Paribas Financial Markets357,358$0.95M0.0%+1,483.4%0.149%Search for SEC Filing on Google Icon
11/13/2025Mackenzie Financial Corp272,958$0.72M0.0%+2,233.0%0.114%Search for SEC Filing on Google Icon
11/13/2025WINTON GROUP Ltd70,896$0.19M0.0%N/A0.030%Search for SEC Filing on Google Icon
11/13/2025Private Advisor Group LLC53,606$0.14M0.0%+33.7%0.022%Search for SEC Filing on Google Icon
11/13/2025Parallel Advisors LLC117,424$0.31M0.0%-7.8%0.049%Search for SEC Filing on Google Icon
11/12/2025Barclays PLC335,609$0.89M0.0%-7.2%0.166%Search for SEC Filing on Google Icon
11/12/2025Victory Capital Management Inc.426,866$1.13M0.0%+1,739.8%0.212%Search for SEC Filing on Google Icon
11/12/2025Royce & Associates LP2,293,488$6.08M0.1%N/A1.138%Search for SEC Filing on Google Icon
11/12/2025Rafferty Asset Management LLC28,251$75K0.0%N/A0.014%Search for SEC Filing on Google Icon
11/12/2025Quantbot Technologies LP179,639$0.48M0.0%N/A0.089%Search for SEC Filing on Google Icon
11/12/2025R Squared Ltd12,283$33K0.0%N/A0.006%Search for SEC Filing on Google Icon
11/12/2025Intech Investment Management LLC99,491$0.26M0.0%-19.1%0.049%Search for SEC Filing on Google Icon
11/10/2025AXQ Capital LP38,930$0.10M0.0%N/A0.019%Search for SEC Filing on Google Icon
11/10/2025China Universal Asset Management Co. Ltd.35,341$94K0.0%-11.2%0.018%Search for SEC Filing on Google Icon
11/7/2025GSA Capital Partners LLP39,011$0.10M0.0%N/A0.019%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.12,092,449$32.05M0.0%+3.2%5.998%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.945,491$2.51M0.0%+68.4%0.469%Search for SEC Filing on Google Icon
11/6/2025Profund Advisors LLC42,188$0.11M0.0%N/A0.021%Search for SEC Filing on Google Icon
11/6/2025ProShare Advisors LLC41,327$0.11M0.0%-14.5%0.020%Search for SEC Filing on Google Icon
11/5/2025Savant Capital LLC43,956$0.12M0.0%+100.9%0.022%Search for SEC Filing on Google Icon
11/5/2025J.W. Cole Advisors Inc.33,900$90K0.0%-22.8%0.017%Search for SEC Filing on Google Icon
11/4/2025Principal Financial Group Inc.190,056$0.50M0.0%-51.7%0.094%Search for SEC Filing on Google Icon
11/3/2025Foundations Investment Advisors LLC40,157$0.11M0.0%-19.9%0.020%Search for SEC Filing on Google Icon
10/31/2025Vanguard Personalized Indexing Management LLC11,089$29K0.0%N/A0.005%Search for SEC Filing on Google Icon
10/31/2025AIGH Capital Management LLC3,000,000$7.95M2.2%N/A1.488%Search for SEC Filing on Google Icon
10/29/2025Wealth Enhancement Advisory Services LLC23,916$63K0.0%+54.1%0.012%Search for SEC Filing on Google Icon
10/23/2025SLT Holdings LLC40,000$0.11M0.1%-20.0%0.020%Search for SEC Filing on Google Icon
10/23/2025SG Americas Securities LLC103,712$0.28M0.0%+338.1%0.051%Search for SEC Filing on Google Icon
10/22/2025North Star Investment Management Corp.35,000$93K0.0%+40.0%0.017%Search for SEC Filing on Google Icon
10/20/2025DHJJ Financial Advisors Ltd.9,430$25K0.0%+209.2%0.005%Search for SEC Filing on Google Icon
10/20/2025Sivia Capital Partners LLC37,929$0.10M0.0%+47.4%0.019%Search for SEC Filing on Google Icon
10/15/2025CWM LLC19,674$52K0.0%+46.5%0.010%Search for SEC Filing on Google Icon
10/9/2025Voya Investment Management LLC37,996$0.10M0.0%-32.8%0.019%Search for SEC Filing on Google Icon
10/7/2025Sanders Morris Harris LLC20,073$53K0.0%N/A0.010%Search for SEC Filing on Google Icon
8/19/2025State of Wyoming122,532$0.12M0.0%+36.2%0.061%Search for SEC Filing on Google Icon
8/15/2025Wasatch Advisors LP10,340,261$10.18M0.1%-5.4%5.217%Search for SEC Filing on Google Icon
8/15/2025Brevan Howard Capital Management LP78,715$77K0.0%+139.0%0.040%Search for SEC Filing on Google Icon
8/15/2025Bank of America Corp DE836,339$0.82M0.0%-45.2%0.422%Search for SEC Filing on Google Icon
8/14/2025The Manufacturers Life Insurance Company 72,705$72K0.0%+7.4%0.037%Search for SEC Filing on Google Icon
8/14/2025Qube Research & Technologies Ltd485,603$0.48M0.0%+238.3%0.245%Search for SEC Filing on Google Icon
8/13/2025Diametric Capital LP678,824$0.67M0.4%+57.8%0.342%Search for SEC Filing on Google Icon
8/13/2025Marshall Wace LLP5,312,252$5.21M0.0%+46.2%2.680%Search for SEC Filing on Google Icon
8/13/2025Two Seas Capital LP9,954,975$9.80M0.2%+43.6%5.023%Search for SEC Filing on Google Icon
8/13/2025Invesco Ltd.493,929$0.49M0.0%+93.3%0.249%Search for SEC Filing on Google Icon
8/12/2025Rhumbline Advisers275,688$0.27M0.0%+16.8%0.139%Search for SEC Filing on Google Icon
8/12/2025JPMorgan Chase & Co.561,396$0.55M0.0%-70.8%0.283%Search for SEC Filing on Google Icon
8/8/2025Intech Investment Management LLC123,040$0.12M0.0%+30.4%0.062%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC4,583,988$4.51M0.0%+3.1%2.313%Search for SEC Filing on Google Icon
8/6/2025Summit Wealth Group LLC323,000$0.32M0.1%+10.2%0.163%Search for SEC Filing on Google Icon
7/24/2025Boomfish Wealth Group LLC45,306$45K0.0%+29.5%0.023%Search for SEC Filing on Google Icon
7/15/2025North Star Investment Management Corp.25,000$25K0.0%N/A0.013%Search for SEC Filing on Google Icon
7/11/2025UMB Bank n.a.170,000$0.17M0.0%N/A0.086%Search for SEC Filing on Google Icon
7/9/2025Sivia Capital Partners LLC25,738$25K0.0%N/A0.013%Search for SEC Filing on Google Icon
7/8/2025Parallel Advisors LLC127,424$0.13M0.0%+1,174.2%0.064%Search for SEC Filing on Google Icon
5/19/2025Jane Street Group LLC180,227$0.26M0.0%-48.3%0.091%Search for SEC Filing on Google Icon
5/16/2025Goldman Sachs Group Inc.1,527,286$2.20M0.0%-44.5%0.771%Search for SEC Filing on Google Icon
5/16/2025Jones Financial Companies Lllp192,743$0.28M0.0%N/A0.097%Search for SEC Filing on Google Icon
5/16/2025Two Seas Capital LP6,930,871$9.98M0.3%-40.0%3.498%Search for SEC Filing on Google Icon
5/16/2025AQR Capital Management LLC61,887$89K0.0%-68.7%0.031%Search for SEC Filing on Google Icon
5/15/2025Graham Capital Management L.P.487,735$0.70M0.0%+153.5%0.246%Search for SEC Filing on Google Icon
5/15/2025State of Wyoming89,936$0.13M0.0%+93.8%0.045%Search for SEC Filing on Google Icon
5/14/2025MetLife Investment Management LLC74,786$0.11M0.0%-36.5%0.038%Search for SEC Filing on Google Icon
5/14/2025CW Advisors LLC46,300$74K0.0%N/A0.023%Search for SEC Filing on Google Icon
5/14/2025Summit Financial LLC65,194$94K0.0%+40.1%0.033%Search for SEC Filing on Google Icon
5/14/2025Wellington Management Group LLP761,980$1.10M0.0%+36.0%0.385%Search for SEC Filing on Google Icon
5/12/2025Meridian Wealth Management LLC20,000$29K0.0%N/A0.010%Search for SEC Filing on Google Icon
5/12/2025Nuveen LLC3,087,700$4.45M0.0%N/A1.558%Search for SEC Filing on Google Icon
5/12/2025Virtu Financial LLC35,909$52K0.0%-72.8%0.018%Search for SEC Filing on Google Icon
5/12/2025Invesco Ltd.255,480$0.37M0.0%+161.1%0.129%Search for SEC Filing on Google Icon
5/12/2025Connor Clark & Lunn Investment Management Ltd.822,618$1.19M0.0%-11.7%0.415%Search for SEC Filing on Google Icon
5/9/2025Deutsche Bank AG125,784$0.18M0.0%-24.3%0.063%Search for SEC Filing on Google Icon
5/9/2025Headlands Technologies LLC38,447$55K0.0%-84.9%0.019%Search for SEC Filing on Google Icon
5/7/2025SLT Holdings LLC50,000$72K0.1%+66.7%0.025%Search for SEC Filing on Google Icon
5/7/2025Foundations Investment Advisors LLC50,172$72K0.0%+66.3%0.025%Search for SEC Filing on Google Icon
5/7/2025Mackenzie Financial Corp123,115$0.18M0.0%-14.1%0.062%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Esperion Therapeutics logo
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C). Its marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease who require additional lowering of LDL-C. The company's products also include NILEMDO, an ATP Citrate Lyase (ACL) inhibitor that lowers LDL-C and cardiovascular risk by reducing cholesterol biosynthesis and up-regulating the LDL receptors; and NUSTENDI, a bempedoic acid and ezetimibe tablet to treat elevated LDL-C. The company has license and collaboration agreements with Daiichi Sankyo Co. Ltd to; Otsuka Pharmaceutical Co., Ltd; and Daiichi Sankyo Europe GmbH. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.
Read More on Esperion Therapeutics

Today's Range

Now: $3.79
Low: $3.76
High: $3.91

50 Day Range

MA: $2.99
Low: $2.45
High: $4.00

52 Week Range

Now: $3.79
Low: $0.69
High: $4.03

Volume

4,725,351 shs

Average Volume

7,200,330 shs

Market Capitalization

$906.04 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.01

Who are the company insiders with the largest holdings of Esperion Therapeutics?

Esperion Therapeutics' top insider investors include:
  1. Benjamin Halladay (CFO)
  2. Benjamin Looker (General Counsel)
  3. Eric Warren (Insider)
Learn More about top insider investors at Esperion Therapeutics.

Who are the major institutional investors of Esperion Therapeutics?

Esperion Therapeutics' top institutional shareholders include:
  1. Vanguard Group Inc. — 6.00%
  2. Two Seas Capital LP — 4.08%
  3. Wasatch Advisors LP — 2.95%
  4. AIGH Capital Management LLC — 1.49%
  5. Marshall Wace LLP — 1.05%
  6. Royce & Associates LP — 1.14%
Learn More about top institutional investors of Esperion Therapeutics stock.

Which major investors are selling Esperion Therapeutics stock?

During the last quarter, ESPR stock was sold by these institutional investors:
  1. Wasatch Advisors LP
  2. Marshall Wace LLP
  3. Woodline Partners LP
  4. Bank of America Corp DE
  5. UBS Group AG
  6. Two Seas Capital LP
  7. Principal Financial Group Inc.
  8. Prelude Capital Management LLC
Within the last year, company insiders that have sold Esperion Therapeutics company stock include:
  1. Benjamin Halladay (CFO)
  2. Benjamin Looker (General Counsel)
Learn More investors selling Esperion Therapeutics stock.

Which major investors are buying Esperion Therapeutics stock?

During the last quarter, ESPR stock was acquired by institutional investors including:
  1. AIGH Capital Management LLC
  2. Royce & Associates LP
  3. Integral Health Asset Management LLC
  4. Millennium Management LLC
  5. Two Sigma Investments LP
  6. Victory Capital Management Inc.
  7. JPMorgan Chase & Co.
  8. Vanguard Group Inc.